02192 MEDLIVE
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 19.09X | Oper Margin | 56.2% |
|---|---|---|---|
| LT Debt/Equity | 0.1% | Net Margin | 52.1% |
| Total Debt/Equity | 0.2% | Return on Equity | 6.9% |
| Price/Book | 1.17X | Return on Assets | 6.5% |
| (HKD 8.610) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 372.15 | 335.16 | 267.06 | 131.54 | 49.68 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +11.0 | +25.5 | +103.0 | +164.8 | -50.9 |
| Earnings Per Share (HKD) | 0.508 | 0.46 | 0.37 | 0.184 | 0.081 |
| Earnings Per Share Growth (%) | +10.4 | +24.3 | +100.9 | +128.4 | -57.4 |
| Dividend Per Share (HKD) | 0.291 | 0.280 | 0.254 | 0.075 | 0.021 |
| P/E* (X) | 16.96 | 18.73 | 23.28 | 46.77 | 106.82 |
| Yield (%) | 3.38 | 3.25 | 2.95 | 0.87 | 0.24 |
| Dividend Share (%) | 57.25 | 60.91 | 68.67 | 40.58 | 25.93 |
| Book NAV (HKD) | 7.345 | 6.964 | 6.970 | 6.879 | 6.772 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 642.155 | 558.455 | +15.0 | 412.004 |
| Operating Result | 360.288 | 340.474 | +5.8 | 253.127 |
| Associates | 0 | 0 | N/A | 0.005 |
| Profit Before Taxation | 360.288 | 340.474 | +5.8 | 253.132 |
| Taxation | 12.399 | 10.173 | +21.9 | 1.372 |
| Profit /( Loss) After Taxation | 347.889 | 330.301 | +5.3 | 251.76 |
| Minority Interests | 13.548 | 15.155 | -10.6 | 9.459 |
| Net Profit | 334.341 | 315.146 | +6.1 | 242.301 |
| Earnings Per Share () | 0.5076 | 0.4597 | +10.4 | 0.3699 |
| Dividend Per Share () | 0.2906 | 0.2800 | +3.8 | 0.2540 |
| Announcement Date | 2026-03-26 | 2025-03-24 | NA | 2024-03-25 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
